Printer Friendly

Immuno-Response in Diabetics doctoral thesis discussed.

Manama, Sept. 11 (BNA): A scientific study at the Arabian Gulf University (AGU) examined the immune response of Type 2 Diabetes (DM) in patients who have high and low levels of C-peptide related to peripheral neuropathy.

The study which was done by researcher Noora Ali Al Hamar as part of the requirements towards her PhD in Molecular Medicine and Genetic Science, recommended to carry out further studies that contain a huge number of specimens, especially that this disease is wide-spread across Bahrain and GCC States.

The researcher, during discussing her study at AGU, said: "The importance of this research stems from the fact that it's linked to the complications that strain the patients. We need to expand with regards to the conduction of more comprehensive studies that include studying all the factors and complications that diabetics suffer from." The study covered type 2 diabetes patients who have peripheral neuropathy and it used C-peptide as a tool for examination as it plays a key role in pathological mechanisms of peripheral neuropathy in diabetics. The researcher noticed that the C-peptide material played a key role in reducing some of the effects of inflammatory resulted from peripheral neuropathy.

Al Hamar pointed out that the material could be used for the treatment of type 2 diabetes patients to prevent the expansion of neurological problems and complications associated with type 2 diabetes. The study included 131 diabetics and 81 nondiabetics from Bahrain. Furthermore, the response of cytokines was estimated at the LRNA DNA level, and the Enzyme-Linked Immuno-sorbant Assay (ELISA) scale was used to measure cytokine levels in the supernatant of cultured cells from the studied groups.

The researcher also said the study didn't find statistically significant differences when comparing the effects of C-peptide in the production of cytokines with positive control in all the studied groups. She added: "In the future, this substance (C-peptide) will undoubtedly reduce the problems or causes of the nerve limbs and the consequent suffering of patients with type 2 diabetes.". The discussion panel included Molecular Medicine and Genetics Professor at AGU Dr. Moiz Bakhiet, Microbiology Professor at the College of Medicine in Imam Abdulrahman Bin Faisal University Dr. Obaid Al Turaifi as external examiner and Molecular Medicine and Genetics Assistant Professor in AGU Dr. Ghada Al Kafaji as internal examiner.

I.Y

BNA 0849 GMT 2019/09/11

Publishing Rights Reserved to Bahrain News Agency [c] 2003 - 2019 Provided by SyndiGate Media Inc. ( Syndigate.info ).

COPYRIGHT 2019 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Bahrain News Agency
Geographic Code:7BAHR
Date:Sep 11, 2019
Words:406
Previous Article:GCC condemns Israeli PM's plan to annex Palestinian lands.
Next Article:Israeli bulldozers demolish two Palestinian buildings.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters